Vaccination with the now-available pneumococcal vaccine is recommended for persons with diseases and other conditions predisposing to the development of bacteremic pneumococcal pneumonia or increased risk of death from such infection. The value of vaccination on the basis of advanced age is not clear at this time. The vaccine will not eliminate all risk of pneumococcal pneumonia and patients with some immune deficiency states may not respond adequately to the vaccine. Revaccination should not be done at intervals of less than five years. More data are needed from adequately designed and executed studies of benefit from the vaccine in healthy elderly persons and high-risk populations. Physicians should pay particular attention to specific diagnostic needs in pneumococcal infection.
Pneumococcal Vaccine Recommendation. Ann Intern Med. ;96:206–207. doi: 10.7326/0003-4819-96-2-206
Download citation file:
Published: Ann Intern Med. 1982;96(2):206-207.
Infectious Disease, Prevention/Screening, Streptococcal Infections, Vaccines/Immunization.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use